OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11302	Companies
251207	Keywords
180268	Articles
137071	Press releases

Home
Companies
OXURION

BRIEF

published on 06/30/2025 at 18:05, 1 year 4 months ago

Oxurion Reports Transparency Notification from Atlas Special Opportunities

Transparency Notification Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 06/30/2025 at 18:05, 1 year 4 months ago

Oxurion publie une notification de transparence d'Atlas Special Opportunities

Actionnariat Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 06/30/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE

published on 06/30/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
BRIEF

published on 06/25/2025 at 18:05, 1 year 4 months ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Notification Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 06/25/2025 at 18:05, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/25/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en onder drempel van 15% gegaan. Bedrijf richt zich op therapeutische innovatie met technologieën voor klinisch onderzoek

Transparantiekennisgeving Aandelen Oxurion NV Atlas Special Opportunities II LLC Therapeutische Innovatie
PRESS RELEASE

published on 06/25/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies

Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV
BRIEF

published on 06/19/2025 at 08:35, 1 year 4 months ago

Oxurion to Acquire Preclinical Microbiology CRO in Toulouse

Acquisition Diversification Toulouse Oxurion Microbiology CRO
BRIEF

published on 06/19/2025 at 08:35, 1 year 4 months ago

Oxurion acquiert une CRO en microbiologie préclinique à Toulouse

Acquisition Diversification Toulouse Oxurion CRO En Microbiologie

Accesswire

Published on 11/10/2026 at 08:00, 1 hour 3 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 6 hours 18 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 9 hours 53 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 10 hours 3 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 10 hours 31 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 08:42, 20 minutes ago

KSB reports strong order intake in third quarter
Published on 11/10/2026 at 08:30, 33 minutes ago

Restoration - Notting Hill Genesis
Published on 11/10/2026 at 08:25, 37 minutes ago

ZPMC-Led Smart Port Machinery Alliance Reports Growing Industry Collaboration at Annual Meeting
Published on 11/10/2026 at 08:15, 47 minutes ago

EOS Holding - Gen Z and millennials: tech-savvy, financially under pressure
Published on 11/10/2026 at 08:10, 52 minutes ago

ANTHBOT Announces $250 / €250 Black Friday Discounts on M5 and M9 Robotic Lawn Mowers

Les Echos

Published on 11/10/2026 at 07:00, 2 hours 3 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 2 hours 3 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 14 hours 33 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 14 hours 33 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 15 hours 18 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE